In carcinoma-complex cells, the level of fold change in MAGE-B1, -B4, -B5, and -B10 mRNA expression in cells treated with 5-aza-CdR or 5-aza-CdR followed by TSA was higher than in the control group. The gene discussed is MAGEB1; the disease is carcinoma.